Skip to main content

Post-IPO Debt Biotechnology Companies

Explore 90 biotechnology startups that raised post-ipo debt funding. Access verified founder contact information and fundraising data.

Total Companies
90
Total Funding
$10.3B
Avg Funding
$411.4M
Cities
23

Export 90 Post-IPO Debt Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Carlsbad, United States
$35.0M
raised

Acutus Medical develops medical technologies to treat complex cardiac arrhythmia.

Apr 2022
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

San Juan, Puerto Rico
$22.5M
raised

Aspire Biopharma is a biotechnology company that develops nano technology drug formulation technology and medicinal products.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

San Diego, United States
$9.7M
raised

Irras is a commercial-stage medical technology company.

Apr 2023
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Melbourne, Australia
$600.0M
raised

Telix Pharmaceuticalsis a clinical-stage biotechnology company focused on the development of diagnostic and therapeutic products.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ørsta, Norway
$1.5M
raised

Arctic Bioscience is a biotech company that produces bioactive marine-based pharmaceutical and nutraceutical products and solutions.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Menlo Park, United States
$10.0M
raised

Forum Markets developing novel drugs for treating distinct inflammatory diseases.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Chicago, United States
$11.2M
raised

Cardio Diagnostics makes heart disease prevention and early detection more accessible, personalized, and precise.

Mar 2023
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Miami, United States
$1.4M
raised

CLS focuses on the extraction and conversion of cannabinoids in the United States.

Mar 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$100.0M
raised

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Foster City, United States
$2.0M
raised

Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Calabasas, United States
$7.0M
raised

Turn Therapeutics is a pharmaceutical company that is dedicated to reducing the human and economic costs of infection and skin disease.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$605K
raised

Albert Labs is a pharmaceutical drug development company pursuing regulatory approval for active compounds to treat mental health.

Mar 2023
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

La Jolla, United States
$75.0M
raised

Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Mölndal, Sweden
$9.2M
raised

Cinclus Pharma is a research based biotech company.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Richmond, United States
$450.0M
raised

Indivior is a specialty pharmaceuticals business.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$550.0M
raised

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Emeryville, United States
$80.0M
raised

Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.

Feb 2022
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

North Chicago, United States
$8.0B
raised

AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics.

Feb 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$100.0M
raised

Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.

Feb 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$714K
raised

OCT is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research.

Feb 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Markham, Canada
$1.0M
raised

Canntab Therapeutics is a biopharmaceutical company that aims at manufacturing & distributing hard pill cannabinoid formulations.

Feb 2022
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$200.0M
raised

Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.

Dec 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Fort Collins, United States
$7.1M
raised

Enlitic builds AI deep learning products to streamline radiologists' workflows and improve healthcare diagnosis.

Dec 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Florham Park, United States
$10.0M
raised

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

Dec 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$535K
raised

Awakn Life Sciences is an ecosystem for psychedelic-based treatments.

Dec 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Showing 51 to 75 of 90 companies

Ready to Connect with Post-IPO Debt Biotechnology Startups?

Get verified founder emails, funding details, and company data for 90 post-ipo debt biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked